{"product_id":"trelegy-polvo-200mcg-62-5mcg-25mcg-30d-fluticasona-umeclidino-vilanterol","title":"Trelegy Powder 200Mcg\/62.5Mcg\/25Mcg 30D (Fluticasone\/Umeclidinium\/Vilanterol)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedication for the treatment of respiratory diseases.\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eTreatment for COPD and asthma.\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eTrelegy\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eFluticasone\/Umeclidinium\/Vilanterol\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e200Mcg\/62.5Mcg\/25Mcg inhalation powder, 30 doses.\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eGlaxo Smith Kline\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eTrelegy is indicated for the treatment of adult patients with chronic obstructive pulmonary disease (COPD) and\/or asthma. This medication combines a corticosteroid (fluticasone) to reduce inflammation, an anticholinergic (umeclidinium) to relax airway muscles, and a long-acting beta-agonist (vilanterol) that helps open the airways. Specific indications include:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eManagement of persistent symptoms in COPD.\u003c\/li\u003e\n    \u003cli\u003ePrevention of exacerbations in patients with moderate to severe COPD.\u003c\/li\u003e\n    \u003cli\u003eSymptom control in asthmatic patients requiring additional treatment to their current therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach dose of Trelegy contains:\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003eFluticasone: 200 mcg\u003c\/li\u003e\n    \u003cli\u003eUmeclidinium: 62.5 mcg\u003c\/li\u003e\n    \u003cli\u003eVilanterol: 25 mcg\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eTrelegy is contraindicated in patients with known hypersensitivity to any of the components of the formula. Its use is not recommended in patients with severe or uncontrolled asthma, or in those with chronic obstructive pulmonary disease who are not receiving adequate treatment.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised in patients with a history of cardiovascular diseases, hypertension, diabetes mellitus, and thyroid disorders. Additionally, the use of Trelegy should be evaluated in patients with respiratory or systemic infections.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore at room temperature, between 15°C and 30°C, protected from light and moisture. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Glaxo Smith Kline","offers":[{"title":"Default Title","offer_id":45849140068577,"sku":"7501027800169","price":2148.5,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/7501027800169.jpg?v=1744693270","url":"https:\/\/wecarepharma.mx\/en\/products\/trelegy-polvo-200mcg-62-5mcg-25mcg-30d-fluticasona-umeclidino-vilanterol","provider":"WeCare Pharma","version":"1.0","type":"link"}